Mini review · 30 Apr 2024
Short communicationPublished 25 Jun 2021
AlgoLight, a photobioreactor platform for microalgae-based biopharmaceuticals
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Microalgae are explored as a next-generation platform to produce biopharmaceuticals. Compared to current methods (mammalian cells, yeast, bacteria), plant-based techniques have the advantages of higher biosynthetic capacity, genetic engineering flexibility, absence of human pathogens, and finally lower cost. Photosynthetic microalgae have been proven at the lab scale to be a viable option for recombinant protein production, due to successful genes expression. On the way to commercialization, process development is now critical. A process using genetically modified microorganisms must meet the regulatory legislation (UE Directive 2009/41/CE 6 May 2009). The production of microalgae in low-cost open systems can be easily contaminated and cannot avoid the spread of strains into the environment. A containment is possible in closed bioreactors, but the axenic character is not guaranteed, the control of the growth parameters is complex, the poor light distribution (either solar or artificial) is the limiting factor leading to low productivity. AlgoLight (www.algolight.com), in cooperation with the University of Nantes, has developed a photobioreactor with internal volumetric illumination: PRIAM has a very high specific light area (up to 500 m1), thus making it extremely productive and compact. The technology is based on a multilayer stack of double-sided light-emitting Lightex® plates, incorporating woven optical fibers fabrics fed by LEDs. The volumic productivity of a fermenter can now be reached in a photosynthetic process. Opening a way to the cGMP-compliant production of plant based therapeutic proteins in large-scale systems, our PRIAM photobioreactor is currently being scaled-up into a preindustrial platformdetails summary { cursor: pointer; color: #ffff; } a { font-size: 11px; opacity: 0.5; }ReferencesPlaces to Visit in Poland Blog | Places to Visit in Hungary
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Review article · 15 Jul 2016
On the way to commercializing plant cell culture platform for biopharmaceuticals: present status and prospect
Conference abstract · 17 Aug 2015
The review of fl exible production platforms for pharma/biopharmaceutical processing
Conference abstract · 2015
The review of flexible production platforms for pharma/biopharmaceutical processing
Editorial · 2015
Mass Propagation of Plant Cells – An Emerging Technology Platform for Sustainable Production of Biopharmaceuticals
More from this journal
The newest in Journal of Drugs and Ecotoxicology.
Perspective · 29 Mar 2022
Drug safety in patients taking methotrexate for inflammatory arthritis
Opinion · 29 Mar 2022
Typologies are created for both criminal and drug-using behavior
Opinion · 29 Mar 2022
Modern techniques for manufacturing polymer-based drug delivery matrix
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Drugs and Ecotoxicology
- SubjectPharmaceutical Sciences
- SubjectToxicology
- BylineArticles whose byline prints “Jean François Jenck”

